Literature DB >> 30409547

Prescription and Nonprescription Sleep Product Use Among Older Adults in the United States.

Donovan T Maust1, Erica Solway2, Sarah J Clark3, Matthias Kirch2, Dianne C Singer2, Preeti Malani4.   

Abstract

OBJECTIVE: Older adults commonly use products that may be used to promote sleep, such as benzodiazepines and over-the-counter medications, but the current extent of use of both prescription and nonprescription products specifically for sleep in the United States is unknown.
METHODS: Respondents in this cross-sectional, nationally representative survey (the National Poll on Healthy Aging) of community-dwelling older adults aged 65-80 (n = 1,065) reported difficulty initiating sleep or early awakening ("sleep symptoms") and use of prescription medication or nonprescription aids to promote sleep ("sleep product"), including prescription sleep medication, over-the-counter (OTC) sleep aids, prescription pain medication, and herbal/natural sleep aids. Logistic regression was used to determine the association of respondent sociodemographic and clinical characteristics with the use of sleep products.
RESULTS: Sleep symptoms were endorsed by 67.7% of respondents (95% confidence interval [CI] 64.7%-70.7%). Use of a sleep product was reported by 35.4% (95% CI 32.4%-38.6%), with 21.9% (95% CI 19.4%-24.7%) using OTC sleep aids, 12.5% using herbal/natural aids (95% CI 10.6%-14.8%), 8.3% using prescription sleep medication (95% CI 6.7%-10.3%), and 5.0% using prescription pain medication (95% CI 3.8%-6.7%). Self-reported fair/poor mental health (relative to excellent/very good) was associated with increased odds of sleep product use (adjusted odds ratio 2.28, 95% CI 1.10-4.72, p = 0.03).
CONCLUSION: More than a third of older adults use medications or aids to help with sleep-most commonly OTC aids. Clinicians should routinely ask older patients about sleep-related difficulties and the use of nonprescription sleep aids.
Copyright © 2018 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sleep; insomnia; medication; older adult; over-the-counter

Mesh:

Substances:

Year:  2018        PMID: 30409547     DOI: 10.1016/j.jagp.2018.09.004

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

1.  A pharmacy-based intervention to improve safe over-the-counter medication use in older adults.

Authors:  Aaron M Gilson; Ka Z Xiong; Jamie A Stone; Nora Jacobson; Michelle A Chui
Journal:  Res Social Adm Pharm       Date:  2020-05-13

2.  Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial.

Authors:  Adrian L Lopresti; Stephen J Smith; Alexandra P Metse; Peter D Drummond
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

3.  Melatonin Prescribing in Assisted Living.

Authors:  Punita Peketi; Sheryl Zimmerman; Stephanie Palmertree; Christopher J Wretman; John S Preisser; Philip D Sloane
Journal:  J Am Med Dir Assoc       Date:  2021-11-08       Impact factor: 7.802

4.  Insomnia Diagnosis, Prescribed Hypnotic Medication Use, and Risk for Serious Fall Injuries in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  S Justin Thomas; Swati Sakhuja; Lisandro D Colantonio; Mei Li; Paul Muntner; Kristi Reynolds; C Barrett Bowling
Journal:  Sleep       Date:  2022-03-11       Impact factor: 6.313

5.  Predictors of Emergency Preparedness Among Older Adults in the United States.

Authors:  Sue Anne Bell; Dianne Singer; Erica Solway; Mattias Kirch; Jeffrey Kullgren; Preeti Malani
Journal:  Disaster Med Public Health Prep       Date:  2020-06-01       Impact factor: 1.385

6.  Hypnotic Discontinuation Using a Blinded (Masked) Tapering Approach: A Case Series.

Authors:  Constance H Fung; Jennifer L Martin; Cathy Alessi; Joseph M Dzierzewski; Ian A Cook; Alison Moore; Austin Grinberg; Michelle Zeidler; Lara Kierlin
Journal:  Front Psychiatry       Date:  2019-10-24       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.